Holmium Laser Ablation of the Prostate Versus Photoselective Vaporization of Prostate 60 cc or Less: Short-Term Results of a Prospective Randomized Trial

Elzayat, Ehab A.; Al-Mandil, Majid S; Khalaf, I.; Elhilali, Mostafa

doi:10.1016/j.juro.2009.02.117

Cited by 28 publications

(22 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The blood transfusion rate was 14.2% in patients on warfarin and 14.7% in those on LMWHs. HoLAP is effective in smaller prostates, 92 with reduced transfusion rates. 93 Potassium-titanyl-phosphate (KTP) and lithium triborate lasers are used for photovaporization of the prostate (PVP), which is associated with an especially low rate of bleeding; a 0% transfusion rate has been reported in studies that include patients on anticoagulants.…”

Section: Laser Technologymentioning

confidence: 98%

Prevention and management of TURP-related hemorrhage

2011

View full text Add to dashboard Cite

Transurethral resection of the prostate (TURP) is the most common surgical treatment for benign prostatic hyperplasia (BPH) worldwide, but despite its minimally invasive nature, perioperative bleeding remains a common morbidity. Anticoagulant and antiplatelet medications are increasingly common in this patient population and further contribute to the risk of bleeding and extended hospital stay. Preoperative cessation of anticoagulant and antiplatelet drugs is recommended but requires risk assessment of thrombotic complications. Pharmacologic maneuvers to reduce hemorrhage include perioperative administration of 5α-reductase inhibitors. Technical considerations include the use of hemostatic energy sources such as laser and bipolar technologies. Ultimately, no surgical technique is devoid of bleeding risks, and urologists should be aware of how best to prevent and treat TURP-related hemorrhage.

show abstract

Section: Laser Technologymentioning

confidence: 98%

Prevention and management of TURP-related hemorrhage

2011

View full text Add to dashboard Cite

show abstract

“…Reoperation rates at 1 year were 3.5% and 1.9% for the HoLAP and PVP groups, respectively. Bladder neck contracture (BNC) rates of 3.5% and 7.7% for the HoLAP and PVP groups, respectively, were noted and attributed to the authors' early phase of the learning curve and smaller size of the glands being treated [8].…”

Section: Holmium Laser Ablation Of the Prostatementioning

confidence: 98%

“…A recent 2009 study by Elzayat et al [8] compared HoLAP (80 W system) to PVP (80 W system) for the treatment of glands 60 cc or smaller. They reported a statistically significant increased operative time for HoLAP (69.8 min) as compared to PVP (55.5 min).…”

Section: Holmium Laser Ablation Of the Prostatementioning

confidence: 99%

New Advances in Benign Prostatic Hyperplasia: Laser Therapy

2010

View full text Add to dashboard Cite

Throughout the past decade, numerous techniques for the treatment of benign prostatic hyperplasia have emerged. Laser therapy, in particular, has gained widespread popularity among urologists. Since its inception in 1996, holmium laser enucleation of the prostate (HoLEP) has been evaluated rigorously in the treatment of glands of all sizes. HoLEP has produced superior relief of bladder outlet obstruction as compared to transurethral resection of the prostate based on urodynamics, and has proved equally as effective as open prostatectomy, for the management of very large glands (>100 cc), with lower morbidity. In addition to HoLEP, several newer but less well-studied laser techniques currently are available. These include photoselective laser vaporization utilizing the potassium-titanyl-phosphate (KTP or "green light") laser, thulium laser enucleation, and high-power diode laser vaporization. This report reviews the most current literature on laser therapies utilized in the treatment of benign prostatic hyperplasia with regards to safety, outcome, efficiency, and long-term durability.

show abstract

“…In men with pros-tate sizes greater than 80 mL, Kumar [10] published data showing HoLAP to be efficacious and feasible with a mean lasing time of 77 minutes. In a comparative trial of HoLAP versus photoselective vaporization of the prostate (PVP), Elzayat et al [11] reported in a prospective randomized tri-al of 109 men that HoLAP required more operative time (70 minutes vs. 56 minutes).…”

Section: Holmium Laser Ablation Of the Prostatementioning

confidence: 99%

Current Laser Therapies for the Treatment of Benign Prostatic Hyperplasia

2016

IJSR

View full text Add to dashboard Cite

Abstract:The gold standard for symptomatic relief of bladder outlet obstruction secondary to be-nign prostatic hyperplasia has traditionally been a transurethral resection of the pros-tate (TURP). Over the past decade, however, novel laser technologies that are patient friendly as compared to the con-ventional TURP have been developed. As part of the ongoing quest to minimize complica-tions, shorten hospitalization, improve resection time, and most importantly reduce mortality, laser prostatectomy has continually evolved. Today, there are more varia-tions of laser prostatectomy, each with several differing surgical techniques. Although abundant data are available confirming the safety and feasibility of the various laser systems, future randomized-controlled trials will be necessary to verify which techni-que is superior. In this article, we describe the most common modalities used to perform a laser prostatectomy, mainly, the holmium laser and the potassium-titanyl-phosphate lasers. We also highlight the physical and clinical characteristics of each technology with a review of their efficacy.

show abstract

Holmium Laser Ablation of the Prostate Versus Photoselective Vaporization of Prostate 60 cc or Less: Short-Term Results of a Prospective Randomized Trial

Abstract: Holmium laser ablation and photoselective vaporization of the prostate are safe and effective in patients with benign prostatic hyperplasia with a small to moderate size prostate. Both procedures are easy to learn but holmium laser ablation of the prostate requires a longer operating time.

Cited by 28 publications

References 20 publications

Prevention and management of TURP-related hemorrhage

Prevention and management of TURP-related hemorrhage

New Advances in Benign Prostatic Hyperplasia: Laser Therapy

Current Laser Therapies for the Treatment of Benign Prostatic Hyperplasia

Contact Info

Product

Resources

About